{"id":447,"date":"2023-06-08T09:25:23","date_gmt":"2023-06-08T09:25:23","guid":{"rendered":"https:\/\/ntangels.com\/?page_id=447"},"modified":"2023-06-08T09:25:24","modified_gmt":"2023-06-08T09:25:24","slug":"investmen","status":"publish","type":"page","link":"https:\/\/ntangels.com\/en\/investmen","title":{"rendered":"INVESTMENT"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Owns Newsight Tech Angels LLC as a U.S. subsidiary<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Within the Angel Investment Fund, investment recovery will be made through the following. <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li> Approx. 60%: Investments in Japanese drug discovery seeds and platform technologies<\/li><li>Approx. 20%: Investments in non-Japanese drug discovery seeds and platform technologies<\/li><li>20%: Portfolio investment in U.S. angel funds<\/li><li>As a result of hands-on support:<\/li><li>Licensing to Asian countries including Japan<\/li><li>Partnerships with pharmaceutical companies<\/li><li>Venture capital funding<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologies Approx. 20%: Investments in non-Japanese drug discovery seeds and platform technologies 20%: Portfolio investment in U.S. angel funds As a result of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/ntangels.com\/en\/investmen\" class=\"more-link\">Read more<span class=\"screen-reader-text\"> &#8220;INVESTMENT&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_locale":"en_US","_original_post":"http:\/\/www.ntangels.com\/?page_id=23","sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","vkExUnit_sitemap":"","_veu_custom_css":"","veu_display_promotion_alert":"","_exclude_from_list_pages":"","vkexunit_cta_each_option":"","vkExUnit_childPageIndex":"","vkExUnit_pageList_ancestor":"","vkExUnit_contact_enable":"","inspiro_hide_title":false,"inspiro_hide_featured_image":false,"footnotes":""},"class_list":["post-447","page","type-page","status-publish","hentry","en-US"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/ntangels.com\/en\/investmen\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Newsight Tech Angels - Newsight Tech Angels\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"INVESTMENT - Newsight Tech Angels\" \/>\n\t\t<meta property=\"og:description\" content=\"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/ntangels.com\/en\/investmen\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"208\" \/>\n\t\t<meta property=\"og:image:height\" content=\"63\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-06-08T09:25:23+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-06-08T09:25:24+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"INVESTMENT - Newsight Tech Angels\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ntangels.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ntangels.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen#listItem\",\"name\":\"INVESTMENT\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen#listItem\",\"position\":2,\"name\":\"INVESTMENT\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/ntangels.com#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/#organization\",\"name\":\"Newsight Tech Angels\",\"description\":\"Newsight Tech Angels\",\"url\":\"https:\\\/\\\/ntangels.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ntangels.com\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/NTA-LOGO-white-S-2.png\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen\\\/#organizationLogo\",\"width\":208,\"height\":63},\"image\":{\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen\\\/#organizationLogo\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen#webpage\",\"url\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen\",\"name\":\"INVESTMENT - Newsight Tech Angels\",\"description\":\"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ntangels.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ntangels.com\\\/en\\\/investmen#breadcrumblist\"},\"datePublished\":\"2023-06-08T09:25:23+00:00\",\"dateModified\":\"2023-06-08T09:25:24+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ntangels.com\\\/#website\",\"url\":\"https:\\\/\\\/ntangels.com\\\/\",\"name\":\"Newsight Tech Angels\",\"description\":\"Newsight Tech Angels\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/ntangels.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"INVESTMENT - Newsight Tech Angels","description":"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to","canonical_url":"https:\/\/ntangels.com\/en\/investmen","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/ntangels.com\/en\/investmen#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/ntangels.com#listItem","position":1,"name":"Home","item":"https:\/\/ntangels.com","nextItem":{"@type":"ListItem","@id":"https:\/\/ntangels.com\/en\/investmen#listItem","name":"INVESTMENT"}},{"@type":"ListItem","@id":"https:\/\/ntangels.com\/en\/investmen#listItem","position":2,"name":"INVESTMENT","previousItem":{"@type":"ListItem","@id":"https:\/\/ntangels.com#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/ntangels.com\/#organization","name":"Newsight Tech Angels","description":"Newsight Tech Angels","url":"https:\/\/ntangels.com\/","logo":{"@type":"ImageObject","url":"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png","@id":"https:\/\/ntangels.com\/en\/investmen\/#organizationLogo","width":208,"height":63},"image":{"@id":"https:\/\/ntangels.com\/en\/investmen\/#organizationLogo"}},{"@type":"WebPage","@id":"https:\/\/ntangels.com\/en\/investmen#webpage","url":"https:\/\/ntangels.com\/en\/investmen","name":"INVESTMENT - Newsight Tech Angels","description":"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/ntangels.com\/#website"},"breadcrumb":{"@id":"https:\/\/ntangels.com\/en\/investmen#breadcrumblist"},"datePublished":"2023-06-08T09:25:23+00:00","dateModified":"2023-06-08T09:25:24+00:00"},{"@type":"WebSite","@id":"https:\/\/ntangels.com\/#website","url":"https:\/\/ntangels.com\/","name":"Newsight Tech Angels","description":"Newsight Tech Angels","inLanguage":"en-US","publisher":{"@id":"https:\/\/ntangels.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"Newsight Tech Angels - Newsight Tech Angels","og:type":"article","og:title":"INVESTMENT - Newsight Tech Angels","og:description":"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to","og:url":"https:\/\/ntangels.com\/en\/investmen","og:image":"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png","og:image:secure_url":"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png","og:image:width":208,"og:image:height":63,"article:published_time":"2023-06-08T09:25:23+00:00","article:modified_time":"2023-06-08T09:25:24+00:00","twitter:card":"summary_large_image","twitter:title":"INVESTMENT - Newsight Tech Angels","twitter:description":"Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologiesApprox. 20%: Investments in non-Japanese drug discovery seeds and platform technologies20%: Portfolio investment in U.S. angel fundsAs a result of hands-on support:Licensing to","twitter:image":"https:\/\/ntangels.com\/wp-content\/uploads\/2022\/07\/NTA-LOGO-white-S-2.png"},"aioseo_meta_data":{"post_id":"447","title":null,"description":null,"keywords":[],"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-06-08 09:25:24","updated":"2026-09-08 22:40:07","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/ntangels.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tINVESTMENT\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/ntangels.com"},{"label":"INVESTMENT","link":"https:\/\/ntangels.com\/en\/investmen"}],"veu_head_title_object":{"title":"","add_site_title":""},"featured_media_urls":[],"_links":{"self":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages\/447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/comments?post=447"}],"version-history":[{"count":1,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages\/447\/revisions"}],"predecessor-version":[{"id":448,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages\/447\/revisions\/448"}],"wp:attachment":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/media?parent=447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}